Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

IP vs SC insulin in intensive diabetes management

    • 3 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    IP vs SC insulin in intensive diabetes management. Pharmacoecon. Outcomes News 12, 8 (1994). https://doi.org/10.1007/BF03289868

    Download citation